Ozempic cuts kidney-disease risks, research finds Provided by Dow Jones May 25, 2024, 1:10:00 PM. By Eleanor Laise . Diabetes treatment slows progression of kidney disease and reduces risk of ...

People taking Ozempic in a multinational trial experienced a 24 percent reduction in risk of death from cardiovascular and kidney disease compared with those who received a placebo.

Heart disease and chronic kidney disease are strongly linked, Parikh says, and “unfortunately, they are self-reinforcing”. Adding in type 2 diabetes is like throwing “rocket fuel” onto the ...

Ozempic Cuts Risk of Chronic Kidney Disease Complications, Study Finds A major clinical trial showed such promising results that the drug’s maker halted it early. Listen to this article · 5:16 ...

The study included 3,533 people with kidney disease and Type 2 diabetes, about half of whom took a weekly injection of semaglutide, and half of whom took a weekly placebo shot.

In this trial, which followed more than 3,500 people with type 2 diabetes and chronic kidney disease over an average of 3.4 years, people who took a weekly shot of semaglutide in addition to ...

Ozempic is now FDA-approved to reduce chronic kidney disease risks in diabetes patients. A Phase 3 trial showed Ozempic reduced kidney disease worsening by 24% and heart-related deaths by 5%.

Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.

COPENHAGEN, Denmark — Novo Nordisk's widely used diabetes drug Ozempic delayed the progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of ...

A new study shows the main ingredient in Ozempic and Wegovy, which already help with diabetes and weight loss, may also dramatic cut the risks from chronic kidney disease.Here to answer your ...

Ozempic cuts kidney-disease risks, research finds Diabetes treatment slows progression of kidney disease and reduces risk of death, study shows Last Updated: May 25, 2024 at 9:10 a.m. ET First ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...